Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check3 days agoChange DetectedA new revision tag v3.7.0 was added and the previous tag v3.6.6 was removed, signaling an update to the study record's version.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a new version of the page in the history.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry, v3.6.5, was added to the study record history and the previous revision, v3.6.4, was removed. This update represents changes to the page’s versioning metadata rather than alterations to the study data.SummaryDifference0.1%

- Check60 days agoChange DetectedThe history page now reflects Revision: v3.6.4 instead of v3.6.3. This indicates a new software revision was applied to the Record History page.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry 'Revision: v3.6.3' is added to the history and the previous 'Revision: v3.6.2' is removed, indicating a software release update to the record history.SummaryDifference0.1%

- Check89 days agoChange DetectedThe revision label in the history table changes from v3.6.0 to v3.6.2, representing a minor update to the page metadata. No user-facing content or functionality is altered.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.